Moreover, increased expressions of TNF in the liver and adipose tissue as well as enhanced hepatic TNFR1 transcripts were detected in NASH patients, again correlating with disease progression [66]. This evidence concerns the gene TNFRSF1A and metabolic dysfunction-associated steatohepatitis.